Medical Journals To Follow New Policy
BOSTON-Two prominent American medical journals will no longer let pharmaceutical companies determine conclusions of studies. Instead, editors at The New England Journal of Medicine and The Lancet will rely on the researchers who conducted the work to write the conclusions to their studies.
This decision comes after reported cases of drug companies influencing and pressuring editorial staff members to print articles that incorrectly favored their product. In a few reported cases, companies attempted to block publication of a study if it was not favorable for their company.
Officials at both journals say this decision will give the power to the scientist conducting the experiment. While many studies are funded by pharmaceutical companies, the researchers will now have more independence in reporting their findings, rather than what a pharmaceutical company representative would like to have published.
Information from www.washingtonpost.com
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
